Repurposing simeprevir uncovers a druggable KPNB1-p65-BCL2 survival axis in cancer
Authors:
- Cong LiCLCong Li
- Qiaohua YanQYQiaohua Yan
- Muhammad Muddasar SaeedMSMuhammad Muddasar Saeed
- Yubin LuoYLYubin Luo
- Peidu JiangPJPeidu Jiang
- Qingxiang SunQSQingxiang Sun
- 31 July 2026
- journal article
- Published by Elsevier in Cell Chemical Biology
Abstract
No abstract availableFunding Information
- National Natural Science Foundation of China (82273850)
This publication has 44 references indexed in Scilit:
- Recent advances in canonical versus non-canonical Ca2+-signaling-related anti-apoptotic Bcl-2 functions and prospects for cancer treatmentBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2024
- Therapeutic targeting of nuclear export and import receptors in cancer and their potential in combination chemotherapyIUBMB Life, 2023
- KPNB1-mediated nuclear import in cancerEuropean Journal of Pharmacology, 2023
- It's time to die: BH3 mimetics in solid tumorsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2021
- Cone-shaped HIV-1 capsids are transported through intact nuclear poresCell, 2021
- Karyopherin β1 deletion suppresses tumor growth and metastasis in colorectal cancer (CRC) by reducing MET expressionBiomedicine & Pharmacotherapy, 2019
- Antiviral effects of simeprevir on multiple virusesAntiviral Research, 2019
- Defining a Cancer Dependency MapCell, 2017
- Targeting Phosphatidylinositol 4-Kinase IIIα for Radiosensitization: A Potential Model of Drug Repositioning Using an Anti-Hepatitis C Viral AgentInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2016
- The Karyopherin proteins, Crm1 and Karyopherin β1, are overexpressed in cervical cancer and are critical for cancer cell survival and proliferationInternational Journal of Cancer, 2009